文献速递神经MR

骨架化平均扩散峰宽作为脑淀粉样血管病的神经影像生物标志物

Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-04

本研究纳入24例可能脑淀粉样血管病伴轻度认知障碍患者与62例非脑淀粉样血管病所致轻度认知障碍患者,比较基于DTI的骨架化平均扩散峰宽,发现病例组峰宽增高(P < .001),且与白质高信号体积相关;在脑淀粉样血管病患者中,校正其他小血管病MRI标志后,峰宽增高与加工速度表现更差相关,而在非脑淀粉样血管病组中未发现与认知功能相关。

要点

  • 脑淀粉样血管病伴轻度认知障碍患者的骨架化平均扩散峰宽较非脑淀粉样血管病者增高(P < .001)。
  • 峰宽值与两组白质高信号体积均相关。
  • 脑淀粉样血管病患者中,峰宽增高与加工速度更差相关,独立于其他小血管病MRI标志。

核心结论

  • 骨架化平均扩散峰宽在脑淀粉样血管病中发生改变,并与加工速度表现相关;这种基于DTI的方法可能反映脑淀粉样血管病白质结构破坏程度,并可能成为该人群认知功能的有用生物标志物。

研究设计与样本

  • 研究纳入24例可能脑淀粉样血管病伴轻度认知障碍患者(平均年龄74.7岁,标准差6.0)和62例非脑淀粉样血管病所致轻度认知障碍患者;采用基于DTI的自动化骨架化平均扩散峰宽方法,比较两组间峰宽,并使用线性回归模型探索其与认知功能及脑小血管病常规标志物的关联。

诊断标准与关键数值

  • 脑淀粉样血管病伴轻度认知障碍组骨架化平均扩散峰宽较非脑淀粉样血管病轻度认知障碍组增高(P < .001)。
  • 峰宽值与两组白质高信号体积均相关。
  • 在脑淀粉样血管病患者中,校正其他脑小血管病MRI标志后,较高的峰宽与加工速度表现更差相关。
  • 在非脑淀粉样血管病轻度认知障碍患者中,峰宽与认知功能不相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Whole-brain network connectivity has been shown to be a useful biomarker of cerebral amyloid angiopathy and related cognitive impairment. We evaluated an automated DTI-based method, peak width of skeletonized mean diffusivity, in cerebral amyloid angiopathy, together with its association with conventional MRI markers and cognitive functions.

MATERIALS AND METHODS: We included 24 subjects (mean age, 74.7 [SD, 6.0] years) with probable cerebral amyloid angiopathy and mild cognitive impairment and 62 patients with MCI not attributable to cerebral amyloid angiopathy (non-cerebral amyloid angiopathy-mild cognitive impairment). We compared peak width of skeletonized mean diffusivity between subjects with cerebral amyloid angiopathy-mild cognitive impairment and non-cerebral amyloid angiopathy-mild cognitive impairment and explored its associations with cognitive functions and conventional markers of cerebral small-vessel disease, using linear regression models.

RESULTS: Subjects with Cerebral amyloid angiopathy-mild cognitive impairment showed increased peak width of skeletonized mean diffusivity in comparison to those with non-cerebral amyloid angiopathy-mild cognitive impairment (P < .001). Peak width of skeletonized mean diffusivity values were correlated with the volume of white matter hyperintensities in both groups. Higher peak width of skeletonized mean diffusivity was associated with worse performance in processing speed among patients with cerebral amyloid angiopathy, after adjusting for other MRI markers of cerebral small vessel disease. The peak width of skeletonized mean diffusivity did not correlate with cognitive functions among those with non-cerebral amyloid angiopathy-mild cognitive impairment.

CONCLUSIONS: Peak width of skeletonized mean diffusivity is altered in cerebral amyloid angiopathy and is associated with performance in processing speed. This DTI-based method may reflect the degree of white matter structural disruption in cerebral amyloid angiopathy and could be a useful biomarker for cognition in this population.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Raposo N, Zanon Zotin MC, Schoemaker D, et al. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy. AJNR Am J Neuroradiol. 2021. PMID: 33664113. doi:10.3174/ajnr.A7042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。